101 studies found for:    "Dengue fever"
Show Display Options
Rank Status Study
1 Enrolling by invitation Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Intervention:
2 Completed Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Intervention: Biological: Chimeric dengue serotype (1, 2, 3, 4)
3 Completed Efficacy and Safety of Dengue Vaccine in Healthy Children
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric tetravalent dengue (serotype 1, 2, 3, 4);   Biological: Inactivated Rabies virus vaccine
4 Active, not recruiting Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Disease
Interventions: Biological: Chimeric dengue serotypes (1, 2, 3, 4).;   Biological: Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
5 Completed Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Dengue Virus;   Dengue Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis
6 Active, not recruiting Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus;   Dengue Diseases
Interventions: Biological: CYD Dengue vaccine;   Biological: NaCl + influenza virus or hepatitis A vaccine
7 Completed Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric dengue serotype 1, 2, 3, and 4;   Biological: Pneumococcal polysaccharide vaccine
8 Completed Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero);   Biological: Tetravalent blending VDV-2/CYD-1,3,4 Dengue (Vero);   Biological: Tetravalent CYD-1,2,3,4 Dengue (Vero);   Biological: JE-VAX®: Japanese encephalitis virus vaccine inactivated + Tetravalent CYD-1,2,3,4 Dengue (Vero)
9 Completed Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Intervention:
10 Active, not recruiting Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9%
11 Completed Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9% solution
12 Active, not recruiting Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue
Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9% solution
13 Recruiting Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: CYD Dengue and Japanese Encephalitis Vaccines;   Biological: Japanese Encephalitis and CYD Dengue Vaccines
14 Completed Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus;   Biological: Yellow Fever
15 Completed Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Intervention: Biological: ChimeriVax™ Tetravalent Dengue Vaccine
16 Completed A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Shock Syndrome
Interventions: Other: Placebo;   Biological: Post-Transfection F17;   Biological: Post-Transfection F19
17 Completed Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus;   Biological: Placebo: NaCl 0.9%
18 Completed Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus;   Biological: Placebo: NaCl 0.9%
19 Completed A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus;   Biological: OKAVAX®:Attenuated live varicella-zoster virus and AVAXIM® 80U: Hepatitis A virus Vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and Childhood vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and NaCl (Placebo)
20 Active, not recruiting Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease
Conditions: Dengue Disease;   Dengue Fever
Interventions: Biological: Tetravalent Dengue Vaccine (TVDV);   Biological: Tetravalent Dengue Vaccine (TVDV) with Vaxfectin® (low-dose);   Biological: Tetravalent Dengue Vaccine TVDV with Vaxfectin® (High Dose)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years